Tirosint Month-by-Month: What to Expect in the First 3 Months

Month 1: The Dose Has Not Finished Working Yet

The levothyroxine sodium tablets label states that the peak therapeutic effect of a given dose may not be attained for 4 to 6 weeks [1]. It says adequacy of therapy is determined with periodic TSH and/or T4 monitoring as well as clinical status [1].

Tirosint is a soft gelatin capsule, not a tablet [3]. The Tirosint capsule label says to give it as a single daily dose on an empty stomach, one-half to one hour before breakfast, and at least 4 hours before or after drugs known to interfere with absorption. The tablet label uses the same wording [1]. Tirosint capsules are labeled for adults and children 6 years and older who can swallow the capsule whole; the capsules are not to be cut, crushed or chewed.

For adults with primary hypothyroidism, the tablet label gives a full replacement dose of 1.6 mcg/kg/day and adjustment in 12.5 to 25 mcg increments every 4 to 6 weeks until TSH returns to normal [1]. Adults at risk of atrial fibrillation or with underlying heart disease start below the full replacement dose and are titrated every 6 to 8 weeks instead [1].

Reactions that levothyroxine labeling attributes to too much hormone include palpitations, tachycardia, arrhythmias, angina, tremor, nervousness, insomnia, heat intolerance, sweating, weight loss, increased appetite and diarrhea [1]. The label also says levothyroxine has a narrow therapeutic index, so both too much and too little matter [1].

Month 2: Around the First Dose Adjustment

Dose adjustments for adult primary hypothyroidism are spaced 4 to 6 weeks apart [1]. The 2023 Tirosint capsule study took its first measurement at week 6, at the end of that window. Forty-seven thyroidectomized adults on stable levothyroxine tablets plus a proton pump inhibitor were switched to Tirosint soft capsules at the same daily dose for 12 weeks; 45 finished. Mean TSH fell by 0.32 mIU/L at week 6 and 0.68 mIU/L at week 12, with increased thyroid hormone levels [2]. The study was open-label with no control group, so it shows what happened in that group rather than proving the capsule beats tablets [2].

Everyone in it had a total thyroidectomy and was taking a PPI, so it describes a specific group rather than everyone starting Tirosint [2].

Month 3: Judging the Dose

By week 12, a dose has had longer than the 4-to-6-week peak-effect window, but the tablet label says dose adequacy is judged with periodic TSH and/or T4 testing and clinical status [1]. In the 2023 study the mean TSH change at week 12 was 0.68 mIU/L, larger than the 6-week change [2].

The label makes one exception that changes how month 3 is read: in secondary or tertiary hypothyroidism, TSH is not a reliable measure of dose adequacy and free T4 is used to titrate instead [1].

A TSH above the reference range does not, by itself, show why it is elevated. Calcium, iron and acid-suppressing drugs can all reduce levothyroxine absorption and push TSH up [4][5][1].

What Else Can Move Your TSH in the First Three Months

Tirosint is levothyroxine, and the capsule label still lists these absorption interactions.

Calcium. Twenty adults with hypothyroidism on stable levothyroxine took 1,200 mg of elemental calcium a day with their levothyroxine for three months. Mean TSH rose from 1.6 to 2.7 mIU/L, free T4 fell, and 20% ended with TSH above the normal range [4]. The label says to take levothyroxine at least 4 hours apart from calcium carbonate and ferrous sulfate [1].

Iron. Fourteen patients took 300 mg of ferrous sulfate with their thyroxine every day for 12 weeks. Mean TSH rose from 1.6 to 5.4 mU/L and nine of the 14 had more symptoms of hypothyroidism [5].

Acid-suppressing drugs. The label groups proton pump inhibitors with sucralfate and antacids as drugs that can reduce levothyroxine absorption and says to monitor, with no fixed hour spacing [1]. In one study, omeprazole raised TSH in all 10 patients treated, and a 37% increase in thyroxine dose reversed it [6].

Food. The label says soybean flour, cottonseed meal, walnuts and dietary fiber may bind levothyroxine and decrease absorption, and to evaluate the need for dose adjustments when foods that affect absorption are regularly taken within an hour of the dose [1].

Pregnancy. The label says requirements often rise, that levothyroxine should not be discontinued in pregnancy, that TSH should be monitored and the dose adjusted, and that the dose should return to the pre-pregnancy level immediately after delivery [1].

Hair and Weight: Two Things People Watch For

Hair loss appears in the levothyroxine label's list of dermatologic adverse reactions, along with flushing and rash. The label describes its adverse reactions as primarily those of hyperthyroidism from overdose [1].

Weight is covered by a boxed warning. Thyroid hormones, including levothyroxine, should not be used to treat obesity or for weight loss; in euthyroid people, doses within daily hormonal requirements are ineffective for weight reduction, and larger doses can cause serious or life-threatening toxicity, particularly with sympathomimetic amines [1].

What Month-by-Month Reviews Cannot Tell You

Patient reviews describe energy, hair and mood changing on their own schedules, so a month-by-month symptom timeline is personal experience rather than a measured average. What is documented is the lab side: the 4-to-6-week wait for a dose to peak, the 4-to-6-week titration interval, and the TSH changes seen at 6 and 12 weeks after a same-dose switch to the soft capsule [1][2].